Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 1/2 1Phase 1 1

Status

Terminated 4Completed 3Withdrawn 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Gynecologic 1CNS 1

Conditions

Breast Neoplasms 2Radiation Injuries 1Ovarian Neoplasms 1Noonan Syndrome 1Neurofibromatosis 1 1Cognition Disorders 1Carcinoma, Ovarian Epithelial 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 144Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Lovastatin × Clear all
NCT03504501 2023-11-30

SynCoRAS

Technical University of Munich

Phase 2 Terminated
16 enrolled
CNS

Cognition Disorders, Neurofibromatosis 1, Noonan Syndrome

NCT00585052 2018-01-05

A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer

University of Iowa

Phase 2 Terminated
11 enrolled 8 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00285857 2017-03-09

Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention

Stanford University

Phase 2 Terminated
30 enrolled 7 charts
Breast

Breast Neoplasms

NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Virginia Commonwealth University

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡